A&D Pharma Holdings N.V. Signs Agreement to Acquire Central & Eastern European Private Pharmaceutical Companies A&D Pharma Holdings N.V. Signs Agreement to Acquire Central & Eastern European Private Pharmaceutical Companies

A&D Pharma Holdings N.V. Signs Agreement to Acquire Central & Eastern European Private Pharmaceutical Companies

InPR 2009, Dec 21

    • $5.99
    • $5.99

Publisher Description

BUCHAREST (Romania), Dec 21, 2009 -- (InPR) -- A&D Pharma Holdings N.V. (the "Group", the "Company", or "A&D Pharma"), the Dutch holding company that owns the largest integrated pharmaceutical wholesale, marketing and sales, and retail business in Romania today announces that, further to its announcement of 28 September 2009, the Group has now signed an agreement to acquire Arishop Pharma AD and its subsidiary in Bulgaria, Ozone Laboratories Polska and Ozone Laboratories Polska Services in Poland, Ozone Laboratories Magyarorszag Kft. in Hungary, Ozone Laboratories Slovakia s.r.o. in Slovakia and Ozone Laboratories Czech Republic s.r.o. in the Czech Republic. All the target companies are related parties with A&D Pharma (the ultimate controlling shareholders of A&D Pharma are also the ultimate controlling shareholders of the target companies). The acquisition was agreed for a total consideration of Euro 23,150,000 (Euro twenty threemillion one hundred and fifty thousand). Out of the total consideration for the acquisition, Euro 12,750,000 (Euro twelve million seven hundred and fifty thousand) represents the consideration allocated for the acquisition of Arishop Pharma AD in Bulgaria; Euro 4,000,000 (Euro four million) is conditional upon the acquisition by A&D Pharma of an additional company located in one of the target markets; Euro 6,000,000 (Euro six million) represents the consideration for Ozone Laboratories Polska; the remaining balance of Euro 400,000 (Euro four hundred thousand) represents the consideration for the other target companies which are Ozone Laboratories Polska Services, Ozone Laboratories Magyarorszag Kft., Ozone Laboratories Slovakia s.r.o. and Ozone Laboratories Czech Republic s.r.o.(i.e. Euro 100,000 per company).

GENRE
Business & Personal Finance
RELEASED
2009
21 December
LANGUAGE
EN
English
LENGTH
5
Pages
PUBLISHER
AII Data Processing Ltd.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
64.2
KB

More Books Like This

A&D Pharma: Unaudited Financial Statement for the 12 Months Ended 31 December 2009 A&D Pharma: Unaudited Financial Statement for the 12 Months Ended 31 December 2009
2010
An Analysis of the Initial Adoption of FAS 141 and 142 in the Pharmaceutical Industry. An Analysis of the Initial Adoption of FAS 141 and 142 in the Pharmaceutical Industry.
2006
DRUG INDUSTRY DRUG INDUSTRY
2018
Pharmex Industries - Acquisition of Formulex Group of Companies Pharmex Industries - Acquisition of Formulex Group of Companies
2002
Elcoteq Supplements the Prospectus Relating to the Exchange Offer Elcoteq Supplements the Prospectus Relating to the Exchange Offer
2010
UPEK Proposes Stock-For-Stock Merger with Authentec; Authentec Stockholders to Own 50% of Combined Company UPEK Proposes Stock-For-Stock Merger with Authentec; Authentec Stockholders to Own 50% of Combined Company
2010

More Books by InPR

EFSE Expanding to Four More Countries of the European Eastern Neighbourhood Region EFSE Expanding to Four More Countries of the European Eastern Neighbourhood Region
2009
The Koas. Family is Awarded the Prestigious Us-Based Carnegie Medal of Philanthropy in the 40th Year of the Establishment of the Vehbi Koas. Foundation The Koas. Family is Awarded the Prestigious Us-Based Carnegie Medal of Philanthropy in the 40th Year of the Establishment of the Vehbi Koas. Foundation
2009
Krka Presented January to September Operating Results and Future Plans Krka Presented January to September Operating Results and Future Plans
2009
Specifications About the New Regulated Natural Gas Supply Contracts Specifications About the New Regulated Natural Gas Supply Contracts
2009
Nowadays It is 5 Times More Difficult to Buy an Appartment Than It was 20 Years Ago Nowadays It is 5 Times More Difficult to Buy an Appartment Than It was 20 Years Ago
2009
Isbank's Net Profit at the End of the Third Quarter is TL 2,021 Million on A Consolidated Basis! (Financial Report) Isbank's Net Profit at the End of the Third Quarter is TL 2,021 Million on A Consolidated Basis! (Financial Report)
2009